Skip to content

Advertisement

BMC Cancer

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cells

BMC Cancer201717:540

https://doi.org/10.1186/s12885-017-3504-1

Received: 29 August 2016

Accepted: 24 July 2017

Published: 11 August 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
29 Aug 2016 Submitted Original manuscript
10 Jan 2017 Reviewed Reviewer Report - Nick Woods
28 Feb 2017 Reviewed Reviewer Report - Komaraiah Palle
11 May 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 2
11 May 2017 Submitted Manuscript version 2
24 May 2017 Reviewed Reviewer Report - Nick Woods
10 Jul 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 3
10 Jul 2017 Submitted Manuscript version 3
22 Jul 2017 Author responded Author comments - Zhor Senhaji Mouhri
Resubmission - Version 4
22 Jul 2017 Submitted Manuscript version 4
Publishing
24 Jul 2017 Editorially accepted
11 Aug 2017 Article published 10.1186/s12885-017-3504-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cancer Drug Research Laboratory, Department of Medicine, Division of Medical Oncology, McGill University Health Center/Royal Victoria Hospital

Advertisement